SUZANNE LUTTON, MD

Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan

Insertion of pacemaker and upper and lower heart chamber electrode

Nuclear medicine studies of heart muscle at rest and with stress and spect

Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries

Ultrasound of heart with color-depicted blood flow, rate, direction and valve function

External shock to heart to regulate heart beat

New patient office or other outpatient visit, 60-74 minutes

Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 40-54 minutes

Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

Ultrasound of heart with probe in esophagus, with report

Technetium tc-99m sestamibi, diagnostic, per study dose

Established patient office or other outpatient visit, 30-39 minutes

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Insertion of heart rhythm monitor under skin

Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician

Established patient office or other outpatient visit, 20-29 minutes

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

Programming of dual lead pacemaker system

Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days

Injection, regadenoson, 0.1 mg

Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec

Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days

Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days

Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or

Evaluation of cardiac rhythm monitor system, remote up to 30 days

Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional

Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days

Blood test, thyroid stimulating hormone (tsh)

Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional

Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days

Ultrasound of heart blood flow, valves and chambers

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Blood test, lipids (cholesterol and triglycerides)

Blood test, comprehensive group of blood chemicals

Heart rhythm recording continous external ekg over more than 48 hours up to 7 days

Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes

Blood test, basic group of blood chemicals (calcium, total)

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Magnesium level

Blood creatinine level

Insertion of needle into vein for collection of blood sample

Blood potassium level

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only

Ultrasound of heart with color-depicted blood flow, rate and valve function

Red blood cell concentration measurement

Blood count, hemoglobin